𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Another anti-TNF therapy for patients with Crohn's disease

✍ Scribed by Raymond Cross

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
58 KB
Volume
14
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Fecal calprotectin, lactoferrin, and end
Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease
✍ Taina Sipponen; Erkki Savilahti; PΓ€ivi KΓ€rkkΓ€inen; Kaija-Leena Kolho; Hannu Nuut πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 1 views

Background: Fecal calprotectin and lactoferrin are promising noninvasive biomarkers for intestinal inflammation. In Crohn's disease (CD), during anti-TNF-alpha (TNF-␣) treatment, the clinical significance of these markers has, however, been insufficiently explored. Methods: Among CD patients receiv